16-84479972-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020947.4(MEAK7):āc.1312G>Cā(p.Glu438Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000394 in 1,609,680 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00018 ( 0 hom., cov: 32)
Exomes š: 0.00042 ( 1 hom. )
Consequence
MEAK7
NM_020947.4 missense
NM_020947.4 missense
Scores
2
7
10
Clinical Significance
Conservation
PhyloP100: 7.03
Genes affected
MEAK7 (HGNC:29325): (MTOR associated protein, eak-7 homolog) Involved in several processes, including TOR signaling; positive regulation of protein localization to lysosome; and response to insulin. Located in cytosol; lysosomal membrane; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEAK7 | NM_020947.4 | c.1312G>C | p.Glu438Gln | missense_variant | 8/8 | ENST00000343629.11 | NP_065998.3 | |
MEAK7 | XM_005256075.3 | c.1312G>C | p.Glu438Gln | missense_variant | 9/9 | XP_005256132.1 | ||
MEAK7 | XM_017023511.2 | c.1312G>C | p.Glu438Gln | missense_variant | 8/8 | XP_016879000.1 | ||
MEAK7 | XM_047434410.1 | c.1312G>C | p.Glu438Gln | missense_variant | 8/8 | XP_047290366.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEAK7 | ENST00000343629.11 | c.1312G>C | p.Glu438Gln | missense_variant | 8/8 | 1 | NM_020947.4 | ENSP00000343635 | P1 | |
MEAK7 | ENST00000566995.5 | c.*726G>C | 3_prime_UTR_variant, NMD_transcript_variant | 9/9 | 5 | ENSP00000454265 | ||||
MEAK7 | ENST00000570036.5 | c.*1367G>C | 3_prime_UTR_variant, NMD_transcript_variant | 9/9 | 2 | ENSP00000455332 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152226Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
29
AN:
152226
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000333 AC: 83AN: 249204Hom.: 0 AF XY: 0.000334 AC XY: 45AN XY: 134726
GnomAD3 exomes
AF:
AC:
83
AN:
249204
Hom.:
AF XY:
AC XY:
45
AN XY:
134726
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000417 AC: 607AN: 1457336Hom.: 1 Cov.: 31 AF XY: 0.000446 AC XY: 323AN XY: 724724
GnomAD4 exome
AF:
AC:
607
AN:
1457336
Hom.:
Cov.:
31
AF XY:
AC XY:
323
AN XY:
724724
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000184 AC: 28AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74494
GnomAD4 genome
AF:
AC:
28
AN:
152344
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
35
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2022 | The c.1312G>C (p.E438Q) alteration is located in exon 8 (coding exon 7) of the TLDC1 gene. This alteration results from a G to C substitution at nucleotide position 1312, causing the glutamic acid (E) at amino acid position 438 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
D
M_CAP
Benign
T
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at